Gianfranco Silecchia1, Francesco De Angelis2, Mario Rizzello3, Alice Albanese4, Fabio Longo3, Mirto Foletto4. 1. Division of General Surgery & Bariatric Center of Excellence, Department of Medico-Surgical Sciences and Biotechnology, Hospital ICOT, Sapienza University of Rome, Via F. Faggiana 1668, 04100, Latina, Italy. gianfranco.silecchia@uniroma1.it. 2. Division of General Surgery & Bariatric Center of Excellence, Department of Medico-Surgical Sciences and Biotechnology, Hospital ICOT, Sapienza University of Rome, Via F. Faggiana 1668, 04100, Latina, Italy. francescodeangelis4@alice.it. 3. Division of General Surgery & Bariatric Center of Excellence, Department of Medico-Surgical Sciences and Biotechnology, Hospital ICOT, Sapienza University of Rome, Via F. Faggiana 1668, 04100, Latina, Italy. 4. IFSO Bariatric Center of Excellence, Policlinico Universitario, University of Padova, Via Giustiniani 2, 35128, Padua, Italy.
Abstract
INTRODUCTION: Up to 30 % of patients who have undergone laparoscopic sleeve gastrectomy require revision surgery for inadequate weight loss, weight regain, and/or the development of severe upper gastrointestinal symptoms. The aim of this retrospective study was to evaluate the safety and efficacy of laparoscopic fundectomy (LF) in cases of a residual fundus/neofundus development regarding GERD symptoms. METHODS: The study group comprised 19 patients (17 female; mean BMI 35.4 kg/m(2)) divided into 2 groups. Group A (n = 10) patients with severe GERD and evidence of residual fundus/neofundus, Hiatal hernia with good results in terms of weight loss. Group B (n = 9) patients with severe GERD, a residual fundus/neofundus, inadequate weight loss or weight regain. Fundectomy was indicated when a residual fundus/neofundus was associated with severe GERD symptoms. The presence of a residual fundus/neofundus was assessed by a barium swallow and/or multislice computed tomography. RESULTS: No mortality or intra-operative complications occurred. Five postoperative complications occurred: 2 cases of bleeding, 1 mid-gastric stenosis and 2 leaks (10.5 %). All patients experienced improvements in their GERD symptoms and stopped PPI treatment. Group B exhibited an additional %EWL of 53.4 % at 24 months. CONCLUSION: LF and cruroplasty is feasible and has good results in terms of GERD symptoms control and additional weight loss. The high rate of postoperative complications observed in this series remains a matter of concern. A re-sleeve procedure might be considered as an alternative to RYGB/DS conversion restricted to selected patients.
INTRODUCTION: Up to 30 % of patients who have undergone laparoscopic sleeve gastrectomy require revision surgery for inadequate weight loss, weight regain, and/or the development of severe upper gastrointestinal symptoms. The aim of this retrospective study was to evaluate the safety and efficacy of laparoscopic fundectomy (LF) in cases of a residual fundus/neofundus development regarding GERD symptoms. METHODS: The study group comprised 19 patients (17 female; mean BMI 35.4 kg/m(2)) divided into 2 groups. Group A (n = 10) patients with severe GERD and evidence of residual fundus/neofundus, Hiatal hernia with good results in terms of weight loss. Group B (n = 9) patients with severe GERD, a residual fundus/neofundus, inadequate weight loss or weight regain. Fundectomy was indicated when a residual fundus/neofundus was associated with severe GERD symptoms. The presence of a residual fundus/neofundus was assessed by a barium swallow and/or multislice computed tomography. RESULTS: No mortality or intra-operative complications occurred. Five postoperative complications occurred: 2 cases of bleeding, 1 mid-gastric stenosis and 2 leaks (10.5 %). All patients experienced improvements in their GERD symptoms and stopped PPI treatment. Group B exhibited an additional %EWL of 53.4 % at 24 months. CONCLUSION: LF and cruroplasty is feasible and has good results in terms of GERD symptoms control and additional weight loss. The high rate of postoperative complications observed in this series remains a matter of concern. A re-sleeve procedure might be considered as an alternative to RYGB/DS conversion restricted to selected patients.
Authors: Antonio Iannelli; Anne Sophie Schneck; Patrick Noel; Imed Ben Amor; Daniel Krawczykowski; Jean Gugenheim Journal: Obes Surg Date: 2011-07 Impact factor: 4.129
Authors: Wiebke V Petersen; Tobias Meile; Markus A Küper; Marty Zdichavsky; Alfred Königsrainer; Joachim H Schneider Journal: Obes Surg Date: 2012-03 Impact factor: 4.129
Authors: Marco Rengo; Davide Bellini; Olga Iorio; Carlo Nicola De Cecco; Mario Rizzello; Giuseppe Cavallaro; Marilia Carabotti; Andrea Laghi; Gianfranco Silecchia Journal: Obes Surg Date: 2013-12 Impact factor: 4.129
Authors: Jodok M Fink; Natalie Hoffmann; Simon Kuesters; Gabriel Seifert; Claudia Laessle; Torben Glatz; Ulrich T Hopt; W Konrad Karcz; Goran Marjanovic Journal: Obes Surg Date: 2017-04 Impact factor: 4.129
Authors: Daniel Moritz Felsenreich; Ronald Kefurt; Martin Schermann; Philipp Beckerhinn; Ivan Kristo; Michael Krebs; Gerhard Prager; Felix B Langer Journal: Obes Surg Date: 2017-12 Impact factor: 4.129
Authors: Chetan D Parmar; Kamal K Mahawar; Maureen Boyle; Norbert Schroeder; Shlok Balupuri; Peter K Small Journal: Obes Surg Date: 2017-07 Impact factor: 4.129